Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Wajeeh Khan

FOUND: Wave life sciences crashes deep into oversold territory as obesity drug data disappoints should you buy the dip - You Need To See This

Wave Life Sciences (WVE) shares crashed more than 50% on Mardh 26 after the company’s interim Phase 1 data for its obesity candidate WVE-007 disappointed investors.  

This immense pressure on Thursday saw WVE’s relative strength index (14-day) slip below 20, indicating extremely oversold conditions that often trigger a relief rally. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.